The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ristaben 50 mg film-coated tablets



Merck Sharp & Dohme BV,EU/1/10/621/7-12

Main Information

Trade NameRistaben 50 mg film-coated tablets
Active SubstancesSitagliptin as monohydrate phosphate salt
Dosage FormFilm-coated tablet
Licence HolderMerck Sharp & Dohme BV,
Licence NumberEU/1/10/621/7-12

Group Information

ATC CodeA10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS

Status

License statusAuthorised
Licence Issued15/03/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0131-023-003
Interchangeable List DocumentPDF of Interchangeable List
« Back